Influence of first line chemotherapy strategy depending on primary tumor location in metastatic colorectal cancer.

Date publication

août 2021

Journal

Journal of gastrointestinal oncology

Auteurs

Membres identifiés du Cancéropôle Est :
Dr BERTAUT Aurélie , Pr GHIRINGHELLI François

Tous les auteurs :
Tharin Z, Blanc J, Alaoui IC, Bertaut A, Ghiringhelli F

Lien Pubmed

https://www.ncbi.nlm.nih.gov/pubmed/34532106

Résumé

Primary tumor location (PTL) is a major prognostic factor in metastatic colorectal cancer (mCRC) with left side which present better prognosis than right sided. Uncertainty exists regarding comparative effectiveness of irinotecan or oxaliplatin doublet in mCRC in function of PTL.

Mots clés

Colorectal cancer (CRC), comparative effectiveness research, prognosis factor, sidedness, tumour sidedness

Référence

J Gastrointest Oncol. 2021 Aug;12(4):1509-1517